Comparative efficacy and safety of transdermal oxybutynin and oral tolterodine versus placebo in previously treated patients with urge and mixed urinary incontinence

By Dmochowski R.R.   Sand P.K.   Zinner N.R.   Gittelman M.C.   Davila G.W.   Sanders S.W.   Transdermal Oxybutynin Study Group  

Urology, Vol. 62, Iss. 2, 2003-08 ,pp. : 237-242

Elsevier

Access to resources Recommend Favorite

A comparison of extended-release oxybutynin and tolterodine for treatment of overactive bladder in women

By Sand Peter   Miklos John   Ritter Henry   Appell Rodney  

International Urogynecology Journal, Vol. 15, Iss. 4, 2004-08 ,pp. : 243-248

Springer Publishing Company

Access to resources Recommend Favorite

Long-Term Safety, Tolerability and Efficacy of Extended-Release Tolterodine in the Treatment of Overactive Bladder

By Kreder K.   Mayne C.   Jonas U.  

European Urology, Vol. 41, Iss. 6, 2002-06 ,pp. : 588-595

Elsevier

Access to resources Recommend Favorite

Effectiveness and tolerability of extended-release oxybutynin vs extended-release tolterodine in women with or without prior anticholinergic treatment for overactive bladder

By Anderson Rodney   MacDiarmid Scott   Kell Sherron   Barada James   Serels Scott   Goldberg Roger  

International Urogynecology Journal, Vol. 17, Iss. 5, 2006-10 ,pp. : 502-511

Springer Publishing Company

Access to resources Recommend Favorite

Health-related quality of life of Japanese patients with overactive bladder treated with extended-release tolterodine or immediate-release oxybutynin: a randomized, placebo-controlled trial

By Homma Y.  

World Journal of Urology, Vol. 22, Iss. 4, 2004-08 ,pp. : 251-256

Springer Publishing Company

Access to resources Recommend Favorite